These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31816404)

  • 61. [Interaction between microRNAs and OCT4].
    Chen C; Meng F; Wan H; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):55-8. PubMed ID: 25603874
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma.
    Dong Z; Zeng Q; Luo H; Zou J; Cao C; Liang J; Wu D; Liu L
    Pathol Res Pract; 2012 Sep; 208(9):527-33. PubMed ID: 22824146
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Heat shock instructs hESCs to exit from the self-renewal program through negative regulation of OCT4 by SAPK/JNK and HSF1 pathway.
    Byun K; Kim TK; Oh J; Bayarsaikhan E; Kim D; Lee MY; Pack CG; Hwang D; Lee B
    Stem Cell Res; 2013 Nov; 11(3):1323-34. PubMed ID: 24090933
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Carboxy terminus of HSP70-interacting protein (CHIP) attenuates the stemness of thyroid cancer cells through decreasing OCT4 protein stability.
    Xu Y; Xu G; Dang H; Qu W; Chang D; He X; Li M; Wang Q
    Environ Toxicol; 2021 Apr; 36(4):686-693. PubMed ID: 33270330
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trib2 regulates the pluripotency of embryonic stem cells and enhances reprogramming efficiency.
    Do EK; Park JK; Cheon HC; Kwon YW; Heo SC; Choi EJ; Seo JK; Jang IH; Lee SC; Kim JH
    Exp Mol Med; 2017 Nov; 49(11):e401. PubMed ID: 29170476
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
    Poursani EM; Mehravar M; Soltani BM; Mowla SJ
    Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of stem cell factor SALL4 in leukemogenesis.
    Gao C; Kong NR; Chai L
    Crit Rev Oncog; 2011; 16(1-2):117-27. PubMed ID: 22150312
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An Overview on the Complexity of OCT4: at the Level of DNA, RNA and Protein.
    Mehravar M; Ghaemimanesh F; Poursani EM
    Stem Cell Rev Rep; 2021 Aug; 17(4):1121-1136. PubMed ID: 33389631
    [TBL] [Abstract][Full Text] [Related]  

  • 69. lncRNA PSORS1C3 is regulated by glucocorticoids and fine-tunes OCT4 expression in non-pluripotent cells.
    Mirzadeh Azad F; Malakootian M; Mowla SJ
    Sci Rep; 2019 Jun; 9(1):8370. PubMed ID: 31182783
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sumoylation is important for stability, subcellular localization, and transcriptional activity of SALL4, an essential stem cell transcription factor.
    Yang F; Yao Y; Jiang Y; Lu L; Ma Y; Dai W
    J Biol Chem; 2012 Nov; 287(46):38600-8. PubMed ID: 23012367
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In silico identification of natural product inhibitors against Octamer-binding transcription factor 4 (Oct4) to impede the mechanism of glioma stem cells.
    Nayak C; Singh SK
    PLoS One; 2021; 16(10):e0255803. PubMed ID: 34613998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance.
    Sun B; Xu L; Bi W; Ou WB
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216168
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of transcript factors SALL4 and OCT4 in a subset of non-small cell lung carcinomas (NSCLC).
    Rodriguez E; Chen L; Ao MH; Geddes S; Gabrielson E; Askin F; Zhang H; Li QK
    Transl Respir Med; 2014 Dec; 2(1):10. PubMed ID: 25346886
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The new advance of SALL4 in cancer: Function, regulation, and implication.
    Abouelnazar FA; Zhang X; Wang M; Zhang J; Yu D; Zang X; Zhang J; Li Y; Xu J; Yang Q; Zhou Y; Tang H; Wang Y; Gu J; Zhang X
    J Clin Lab Anal; 2023 May; 37(9-10):e24927. PubMed ID: 37337914
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Production of a monoclonal antibody specific for Pou5f1/Oct4.
    Arakawa T; Yoshimi T; Azuma M; Tachibana T
    Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):229-31. PubMed ID: 23750483
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SALL4: An Intriguing Therapeutic Target in Cancer Treatment.
    Moein S; Tenen DG; Amabile G; Chai L
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010677
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide.
    Liu BH; Jobichen C; Chia CSB; Chan THM; Tang JP; Chung TXY; Li J; Poulsen A; Hung AW; Koh-Stenta X; Tan YS; Verma CS; Tan HK; Wu CS; Li F; Hill J; Joy J; Yang H; Chai L; Sivaraman J; Tenen DG
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7119-E7128. PubMed ID: 29976840
    [TBL] [Abstract][Full Text] [Related]  

  • 78. SALL4, the missing link between stem cells, development and cancer.
    Tatetsu H; Kong NR; Chong G; Amabile G; Tenen DG; Chai L
    Gene; 2016 Jun; 584(2):111-9. PubMed ID: 26892498
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oct4 Gene Expression in Primary Colorectal Cancer Promotes Liver Metastasis.
    Fujino S; Miyoshi N
    Stem Cells Int; 2019; 2019():7896524. PubMed ID: 31191684
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SALL4 Expression in Epithelial Gastric Cancer: Epigenetic or Epiphenomenon?
    Jamma T
    Dig Dis Sci; 2023 Apr; 68(4):1082-1083. PubMed ID: 36877335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.